Defense against HSV-1 in a murine model is mediated by iNOS and orchestrated by the activation of TLR2 and TLR9 in trigeminal ganglia

Journal of Neuroinflammation

Volumn 11, Issue , 2014, Pages

  Zolini, Guilherme P ^a   Lima, Graciela K ^b   Lucinda, Natália ^a   Silva, Mariana A ^a   Dias, Marcela F ^a   Pessoa, Natália L ^a   Coura, Bruna P ^a   Cartelle, Christiane T ^b   Arantes, Rosa Maria E ^b   Kroon, Erna G ^b   Campos, Marco A ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Encephalitis; Host immune response; HSV 1; Innate immunity; Toll like receptors

Indexed keywords

CD8 ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; ENZYME SYNTHESIS; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INNATE IMMUNITY; MALE; MORTALITY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; TRIGEMINUS GANGLION; VIRUS IMMUNITY; WILD TYPE;

ANIMALS; BRAIN; CYTOKINES; DISEASE MODELS, ANIMAL; HEPATITIS B CORE ANTIGENS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; LYMPHOCYTES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; THIOGLYCOLATES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 9; TRIGEMINAL GANGLION; VIRAL CORE PROTEINS;

EID: 84896696726     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-11-20     Document Type: Article

References (46)

1. Roizman B, Knipe DM, Whitley RJ. Herpes Simplex Viruses. Fields Virology 2007, 2502-2601. Pennsylvania, PA: Lippincott Williams & Wilkins, Knipe DM, Howley RM, 5.
2. Davison AJ, Eberle R, Ehlers B, Hayward GS, McGeoch DJ, Minson AC, Pellett PE, Roizman B, Studdert MJ, Thiry E. The order Herpesvirales. Arch Virol 2009, 154:171-177.
3. Schmutzhard E. Viral infections of the CNS with special emphasis on herpes simplex infections. J Neurol 2001, 248:469-477.
4. Arduino PG, Porter SR. Herpes simplex virus type 1 infection: overview on relevant clinico-pathological features. J Oral Pathol Med 2008, 37:107-121.
5. Preston CM. Repression of viral transcription during herpes simplex virus latency. J Gen Virol 2000, 81:1-19.
6. Cunningham AL, Diefenbach RJ, Miranda-Saksena M, Bosnjak L, Kim M, Jones C, Douglas MW. The cycle of human herpes simplex virus infection: virus transport and immune control. J Infect Dis 2006, 194:S11-S18.
7. Hüfner K, Derfuss T, Herberger S, Sunami K, Russell S, Sinicina I, Arbusow V, Strupp M, Brandt T, Theil D. Latency of alpha herpes viruses is accompanied by a chronic inflammation in human trigeminal ganglia but not in dorsal root ganglia. J Neuropathol Exp Neurol 2006, 65:1022-1030.
8. Conrady CD, Drevets DA, Carr DJJ. Herpes simplex type I (HSV-1) infection of the nervous system: is an immune response a good thing?. J Neuroimmunol 2010, 220:1-9.
9. Halford WP, Gebhardt BM, Carr DJJ. Mechanisms of herpes virus type 1 reactivation. J Virol 1996, 70:5051-5060.
10. Bloom DC, Giordani NV, Kwiatkowski DL. Epigenetic regulation of latent HSV-1 gene expression. Biochim Biophys Acta 2010, 1799:246-256.
11. Schiffer JT, Abu-Raddad L, Mark KE, Zhu J, Selke S, Magaret A, Wald A, Corey L. Frequent release of Low amounts of herpes simplex virus from neurons: results of a mathematical model. Sci Transl Med 2009, 1:1-9.
12. Aravalli RN, Peterson PK, Lokensgard JR. Toll-like receptors in defense and damage of the central nervous system. J Neuroimmune Pharmacol 2007, 2:297-312.
13. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003, 21:335-376.
14. Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, Arnold MM, Knipe DM, Finberg RW. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 2004, 101:1315-1320.
15. Mansur DS, Kroon EG, Nogueira ML, Arantes RME, Rodrigues SCO, Akira S, Gazzinelli RT, Campos MA. Lethal encephalitis in myeloid differentiation factor 88-deficient mice infected with herpes simples virus 1. Am J Pathol 2005, 166:1419-1426.
16. Herbst-Kralovetz MM, Pyles RB. Toll-like receptors, innate immunity and HSV pathogenesis. Herpes 2006, 13:37-41.
17. Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 2004, 103:1433-1443.
18. Sato A, Iwasaki A. Induction of antiviral immunity requires toll-like receptor signaling in both stromal and dendritic cell compartments. Proc Natl Acad Sci USA 2004, 101:16274-16279.
19. Lima GK, Zolini GP, Mansur DS, Lima BH, Wischhoff U, Astigarraga RG, Dias MF, Das Gracas Almeida Silva M, Bela SR, Do Valle Antonelli LR, Arantes RM, Gazzinelli RT, Bafica A, Kroon EG, Campos MA. Toll-like receptor (TLR) 2 and TLR9 expressed in trigeminal ganglia are critical to viral control during herpes simplex virus 1 infection. AJP 2010, 177:2433-2445.
20. Marques CP, Hu S, Sheng W, Lokensgard JR. Microglial cells initiate vigourous yet non-protective immune responses during HSV-1 brain infection. Virus Res 2006, 121:1-10.
21. Kodukula P, Liu T, Rooijen N, Jager MJ, Hendricks RL. Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system. J Immunol 1999, 162:2895-2905.
22. Liu T, Tang Q, Hendricks RL. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 infection. J Virol 1996, 70:264-271.
23. Lint A, Ayers M, Brooks AG, Coles RM, Heath WR, Carbone FR. Herpes simplex virus-specific CD8+ T cells can clear established lytic infections from skin and nerves and can partially limit early spread of virus after cutaneous inoculation. J Immunol 2004, 172:392-397.
24. Cook WJ, Kramer MF, Walker RM, Burwell TJ, Holman HA, Coen DM, Knipe DM. Persistent expression of chemokine and chemokine receptor RNAs at primary and latent sites of herpes simplex 1 infection. Virol J 2004, 1:5.
25. Carr DJJ, Campbell IL. Herpes simplex virus type 1 induction of chemokine production is unrelated to viral load in the cornea but not in the nervous system. Viral Immunol 2006, 19:741-746.
26. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004, 75:163-189.
27. Flannagan RS, Cosío G, Grinstein S. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Microbiol 2009, 7:355-366.
28. Lima GK. Cinética De Multiplicação Viral e Análise da Expressão de IFN gama e Quimiocinas em Infecção Murina por Vírus Herpes Simplex 1, MSc dissertation 2007, Belo Horizonte: Universidade Federal de Minas Gerais, Instituto de Ciências Biológicas.
29. Marques CP, Cheeran MC, Palmquist JM, Hu S, Lokensgard JR. Microglia are the major cellular source of inducible nitric oxide synthase during experimental herpes encephalitis. J Neurovirol 2008, 14:229-238.
30. Mansur DS. O Papel dos Receptores do Tipo Toll na Infecção Pelo HSV-1, PhD thesis 2007, Belo Horizonte: Universidade Federal de Minas Gerais, Instituto de Ciências Biológicas.
31. Lima GK. TLR2 e TLR9: Receptores Essenciais Para o Controle da infecção por vírus Herpes Simplex do Tipo 1, PhD thesis 2010, Belo Horizonte: Universidade Federal de Minas Gerais, Instituto de Ciências Biológicas.
32. Nogueira ML, Siqueira RC, Freitas N, Amorim JB, Bonjardim CA, Ferreira PC, Orefice F, Kroon EG. Detection of herpesvirus DNA by the polymerase chain reaction (PCR) in vitreous samples from patients with necrotising retinitis. J Clin Pathol 2001, 54:103-106.
33. Campos MA, Kroon EG. Critical period of irreversible block of Vaccinia virus replication. Rev Bras Microbiol 1993, 24:104-110.
34. Boivin G, Coulombe Z, Rivest S. Intranasal herpes simplex virus type 2 inoculation causes a profound thymidine kinase dependent cerebral inflammatory response in the mouse hindbrain. Eur J Neurosci 2002, 16:29-43.
35. Drapier JC, Wietzerbin J, Hibbs JB. Interferon-gamma andtumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol 1988, 18:1587-1592.
36. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001, 25:386-401.
37. Broberg EK, Nygardas M, Salmi AA, Hukkanen V. Low copy number detection of herpes simplex virus type 1 mRNA and mouse Th1 type cytokine mRNAs by light cycler quantitative real time PCR. J Virol Methods 2003, 112:53-65.
38. Kuhlicke J, Frick JS, Morote-Garcia JC, Rosenberger P, Eltzschig HK. Hypoxia inducible factor (HIF)-1 coordinates induction of toll-like receptors TLR2 and TLR6 during hypoxia. PLoS One 2007, 12:e1364.
39. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
40. Préhaud C, Mégret F, Lafage M, Lafon M. Virus infection switches TLR3 positive human neurons to become strong producers of beta interferon. J Virol 2005, 79:12893-12904.
41. Boivin N, Sergerie Y, Rivest S, Boivin G. Effect of pretreatment with Toll-like receptor agonists in a mouse model of herpes simplex virus type 1 encephalitis. JID 2008, 198:664-672.
42. Pierce AT, DeSalvo J, Foster TP, Kosinski A, Weller SK, Halford WP. Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells. J Gen Virol 2005, 86:2421-2432.
43. Sarangi PP, Kim B, Kurt-Jones E, Rouse BT. Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis. J Virol 2007, 81:11128-11138.
44. Yu L, Quinn MT, Cross AR, Dinauer MC. Gp91(phox) is the heme binding subunit of the superoxide-generating NADPH oxidase. Proc Natl Acad Sci 1998, 95:7993-7998.
45. Karupiah G, Xie Q, Buller RML, Nathan C, Duarte C, MacMicking JD. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 1993, 261:1445-1448.
46. Karupiah G, Harris N. Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites. J Exp Med 1995, 181:2171-2179.